Antimicrobial PK in Infants With Suspected or Confirmed Infection
Public ClinicalTrials.gov record NCT00491426. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Antimicrobial Pharmacokinetics in High Risk Infants (Urinary Proteomics in Antimicrobial/Antifungal-Treated Newborns - add-on Study)
Study identification
- NCT ID
- NCT00491426
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Duke University
- Other
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Interventions
- Ampicillin Drug
- Metronidazole Drug
- Piperacillin/Tazobactam Drug
- Acyclovir Drug
- Amphotericin B Drug
- Ambisome Drug
- Anidulafungin Drug
- Caspofungin Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 120 Days
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2005
- Primary completion
- Sep 30, 2010
- Completion
- Oct 31, 2010
- Last update posted
- Nov 18, 2012
2006 – 2010
United States locations
- U.S. sites
- 6
- U.S. states
- 6
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California at San Diego | La Jolla | California | 92103 | — |
| Children's National Medical Center | Washington D.C. | District of Columbia | 20010 | — |
| Kosair Children's Hospital | Louisville | Kentucky | 40202 | — |
| Children's Hospital of Michigan, Wayne State University | Detroit | Michigan | 48201 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00491426, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2012 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00491426 live on ClinicalTrials.gov.